Alpha 2-HS glycoprotein (AHSG), a serum glycoprotein produced predominantly by hepatocytes, is an important biomarker of near-term mortality in patients with cirrhosis and HCC (Wang et al., 2009). This evidence concerns the gene AHSG and hepatocellular carcinoma.